All the details
Application and admission
The School for Continuing Education verifies all applications for completeness and to ensure that they meet the necessary criteria.
Each application is assessed by the Programme Director and Programme Manager of the MAS and CAS programmes, and a request for admission or rejection is sent by them to the School for Continuing Education.
After your application has been reviewed, you will usually receive a written admission decision 4–6 weeks after receipt, or 2–4 weeks after the deadline for downloading the application.
If your application was successful and you have been admitted to the MAS or CAS programme at ETH Zurich, you will be matriculated automatically. No further confirmation is needed from you.
If you wish to withdraw, please send a written notification to the School for Continuing Education. Notify the school within the deadlines mentioned in the admission letter. In the event of late withdrawal, withdrawal fees will be charged.
“A rewarding course with the right mix of theoretical background, practical skills and hands-on experience using digital technologies from biomarkers to health interventions. Moreover, I could enrich my personal network with brilliant classmates, industry experts and great teachers.”Anne Kilburg, student in the MAS ETH in digital Clinical Research, already completed the two mandatory CAS programmes
Study duration: 2–3 years, maximum duration of study is 4 years.
For an example of study duration, please see Downloadhere (JPEG, 470 KB)vertical_align_bottom.
- A Master's degree acknowledged by ETH or equivalent educational qualifications in life sciences
- At least two years of postgraduate work experience in a relevant field
- Sufficient prior knowledge of statistics and Good Clinical Practice (GCP). Persons who do not have prior knowledge in medical statistics and GCP must successfully complete the relevant courses
- Physicians and healthcare professionals interested in increasing their knowledge about investigating clinical research questions with a specific focus on novel technology
- Professionals working at university hospitals and in other hospitals with access to the necessary infrastructure and research support
- Professionals working in clinical research at pharma and MedTech companies or research organisations
- Professionals working in patient organisations
- Professionals working in the public health sector
- Professionals working in the health and life insurance industry